Correction to: Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance

被引：0

作者：

Mingzhu He

Marco E. Bianchi

Tom R. Coleman

Kevin J. Tracey

Yousef Al-Abed

机构：

[1] Center for Molecular Innovation,Division of Genetics and Cell Biology, Chromatin Dynamics Unit

[2] The Feinstein Institute for Medical Research,undefined

[3] San Raffaele University and San Raffaele Scientific Institute IRCCS,undefined

[4] Center for Biomedical Science,undefined

[5] and Center for Bioelectronic Medicine,undefined

[6] The Feinstein Institute for Medical Research,undefined

来源：

Molecular Medicine | 2018年 / 24卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

After publication of this article (He et al., 2018), the corresponding authors recognised an error in Scheme 1, in particular to section “A. HMGB1/TLR4/MD-2 complex formation”. Above “Step 2: B box binding to MD-2”, the text incorrectly read: “Low affinity / extremely slow off”. In addition, some text was omitted below “TLR4/MD-2”. The correct version of Scheme 1 is included in this Correction article. The original article (He et al., 2018) has been corrected.

引用

共 50 条

[41] Detailed Molecular Interactions between Respiratory Syncytial Virus Fusion Protein and the TLR4/MD-2 Complex In Silico
Akagawa, Mao
Shirai, Tatsuya
Sada, Mitsuru
Nagasawa, Norika
Kondo, Mayumi
Takeda, Makoto
Nagasawa, Koo
Kimura, Ryusuke
Okayama, Kaori
Hayashi, Yuriko
Sugai, Toshiyuki
Tsugawa, Takeshi
Ishii, Haruyuki
Kawashima, Hisashi
Katayama, Kazuhiko
Ryo, Akihide
Kimura, Hirokazu
VIRUSES-BASEL, 2022, 14 (11):
[42] Procyanidin B3 alleviates intervertebral disc degeneration via interaction with the TLR4/MD-2 complex
Shang, Ping
Tang, Qian
Hu, Zhichao
Huang, Shiyuan
Hu, Yuezheng
Zhu, Jianhong
Liu, Haixiao
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (06) : 3701 - 3711
[43] Functional activity of MD-2 polymorphic variant is significantly different in soluble and TLR4-bound forms: Decreased endotoxin binding by G56R MD-2 and its rescue by TLR4 ectodomain
Vasl, Jozica
Prohinar, Polonca
Gioannini, Theresa L.
Weiss, Jerrold P.
Jerala, Roman
JOURNAL OF IMMUNOLOGY, 2008, 180 (09): : 6107 - 6115
[44] TLR4 and MD-2 are up-regulated in inflammatory bowel disease (IBD): Mechanism for dysregulated LPS signaling
Abreu, MT
Thomas, LS
Tesfay, SY
Lukasek, K
Michelsen, KS
Zhou, YH
Hu, B
Wada, A
Hirayama, T
Arditi, M
GASTROENTEROLOGY, 2003, 124 (04) : A338 - A338
[45] Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol
Kawasaki, K
Akashi, S
Shimazu, R
Yoshida, T
Miyake, K
Nishijima, M
JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (03): : 232 - 236
[46] Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody
Bednar, Kyle J.
Tsukamoto, Hiroki
Kachapati, Kritika
Ohta, Shoichiro
Wu, Yuehong
Katz, Jonathan D.
Ascherman, Dana P.
Ridgway, William M.
DIABETES, 2015, 64 (10) : 3614 - 3626
[47] Cardiac HMGB1/TLR4 Activation in Pre-Type 2 Diabetes: A Potential Mechanism Triggering Diabetic Cardiovascular Complications
Vargas, Elizabeth
Li, Ying
Carrillo-Sepulveda, Maria Alicia
FASEB JOURNAL, 2017, 31
[48] MD2 and CD14 mediate toll-like receptor 4 (TLR4) activation by high mobility group box 1 (HMGB1)
Mollen, Kevin
Mollen, Kevin
Kaczorowski, David
Yoneyama, Toshie
Vallabhaneni, Raghuveer
Kilgore, Tina
Bo, Meihua
Lotze, Michael
Billiar, Timothy
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (03) : S28 - S28
[49] Unique properties of the chicken TLR4/MD-2 complex: Selective lipopolysaccharide activation of the MyD88-dependent pathway
Keestra, A. Marijke
van Putten, Jos P. M.
JOURNAL OF IMMUNOLOGY, 2008, 181 (06): : 4354 - 4362
[50] HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling
Wang, Jin
Tian, Xiao-ting
Peng, Zhouyf
Li, Wen-qun
Cao, Yuan-yuan
Li, Ying
Li, Xiao-hui
VASCULAR PHARMACOLOGY, 2019, 117 : 35 - 44

← 1 2 3 4 5 →